Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling.

Vessel plus

Dong Y, Wu H, Dong J, Song K, Rahman HA, Towner R, Chen H.
PMID: 29905336
Vessel Plus. 2017;1:3-11. doi: 10.20517/2574-1209.2016.01. Epub 2017 Mar 31.

Epsins, endocytic adaptor proteins required for internalization of ubiquitylated receptors, are generally upregulated in human cancers. It has been characterized that mice deficient of epsins in the endothelium inhibit tumor growth by dysregulating vascular endothelial growth factor receptor-2 (VEGFR2)...

Cite
Dong Y, Wu H, Dong J, et al. Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel Plus. 2017;1:3-11doi: 10.20517/2574-1209.2016.01.
Dong, Y., Wu, H., Dong, J., Song, K., Rahman, H. A., Towner, R., & Chen, H. (2017). Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel plus, 13-11. https://doi.org/10.20517/2574-1209.2016.01
Dong, Yunzhou, et al. "Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling." Vessel plus vol. 1 (2017): 3-11. doi: https://doi.org/10.20517/2574-1209.2016.01
Dong Y, Wu H, Dong J, Song K, Rahman HA, Towner R, Chen H. Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel Plus. 2017;1:3-11. doi: 10.20517/2574-1209.2016.01. Epub 2017 Mar 31. PMID: 29905336; PMCID: PMC5997290.
Copy Download .nbib Format: NLM
Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.

Journal of nature and science

Dong Y, Cai X, Wu Y, Liu Y, Deng L, Chen H.
PMID: 28191500
J Nat Sci. 2017 Jan;3(1).

The retina is a light sensitive tissue that contains specialized photoreceptor cells called rods and cones which process visual signals. These signals are relayed to the brain through interneurons and the fibers of the optic nerve. The retina is...

Cite
Dong Y, Cai X, Wu Y, et al. Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling. J Nat Sci. 2017;3(1)
Dong, Y., Cai, X., Wu, Y., Liu, Y., Deng, L., & Chen, H. (2017). Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling. Journal of nature and science, 3(1), .
Dong, Yunzhou, et al. "Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling." Journal of nature and science vol. 3,1 (2017).
Dong Y, Cai X, Wu Y, Liu Y, Deng L, Chen H. Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling. J Nat Sci. 2017 Jan;3(1). PMID: 28191500; PMCID: PMC5303005.
Copy Download .nbib Format: NLM
Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression.

Journal of cancer research updates

Tessneer KL, Cai X, Pasula S, Dong Y, Liu X, Chang B, McManus J, Hahn S, Yu L, Chen H.
PMID: 24501612
J Can Res Updates. 2013 Jul 01;2(3):144-150. doi: 10.6000/1929-2279.2013.02.03.2.

Tumor angiogenesis, tumor cell proliferation, and tumor cell migration result from an accumulation of oncogenic mutations that alter protein expression and the regulation of various signaling cascades. Epsins, a small family of clathrin-mediated endocytic adaptor proteins, are reportedly upregulated...

Cite
Tessneer KL, Cai X, Pasula S, et al. Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression. J Can Res Updates. 2013;2(3):144-150doi: 10.6000/1929-2279.2013.02.03.2.
Tessneer, K. L., Cai, X., Pasula, S., Dong, Y., Liu, X., Chang, B., McManus, J., Hahn, S., Yu, L., & Chen, H. (2013). Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression. Journal of cancer research updates, 2(3), 144-150. https://doi.org/10.6000/1929-2279.2013.02.03.2
Tessneer, Kandice L, et al. "Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression." Journal of cancer research updates vol. 2,3 (2013): 144-150. doi: https://doi.org/10.6000/1929-2279.2013.02.03.2
Tessneer KL, Cai X, Pasula S, Dong Y, Liu X, Chang B, McManus J, Hahn S, Yu L, Chen H. Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression. J Can Res Updates. 2013 Jul 01;2(3):144-150. doi: 10.6000/1929-2279.2013.02.03.2. PMID: 24501612; PMCID: PMC3911794.
Copy Download .nbib Format: NLM
Cardiotoxicity of Anticancer Therapeutics.

Frontiers in cardiovascular medicine

Dong J, Chen H.
PMID: 29473044
Front Cardiovasc Med. 2018 Feb 07;5:9. doi: 10.3389/fcvm.2018.00009. eCollection 2018.

As cancer therapeutics continues to improve and progress, the adverse side effects associated with anticancer treatments have also attracted more attention and have become extensively explored. Consequently, the importance of posttreatment follow-ups is becoming increasingly relevant to the discussion....

Cite
Dong J, Chen H. Cardiotoxicity of Anticancer Therapeutics. Front Cardiovasc Med. 2018;5:9doi: 10.3389/fcvm.2018.00009.
Dong, J., & Chen, H. (2018). Cardiotoxicity of Anticancer Therapeutics. Frontiers in cardiovascular medicine, 59. https://doi.org/10.3389/fcvm.2018.00009
Dong, Jerry, and Chen, Hong. "Cardiotoxicity of Anticancer Therapeutics." Frontiers in cardiovascular medicine vol. 5 (2018): 9. doi: https://doi.org/10.3389/fcvm.2018.00009
Dong J, Chen H. Cardiotoxicity of Anticancer Therapeutics. Front Cardiovasc Med. 2018 Feb 07;5:9. doi: 10.3389/fcvm.2018.00009. eCollection 2018. PMID: 29473044; PMCID: PMC5810267.
Copy Download .nbib Format: NLM
Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance.

Frontiers in cardiovascular medicine

Li M, Qian M, Xu J.
PMID: 28848738
Front Cardiovasc Med. 2017 Aug 09;4:51. doi: 10.3389/fcvm.2017.00051. eCollection 2017.

Obesity is a worldwide epidemic that predisposes individuals to metabolic complications, such as type 2 diabetes mellitus and non-alcoholic fatty liver disease, all of which are related to an imbalance between food intake and energy expenditure. Identification of the...

Cite
Li M, Qian M, Xu J. Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Front Cardiovasc Med. 2017;4:51doi: 10.3389/fcvm.2017.00051.
Li, M., Qian, M., & Xu, J. (2017). Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Frontiers in cardiovascular medicine, 451. https://doi.org/10.3389/fcvm.2017.00051
Li, Manna, et al. "Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance." Frontiers in cardiovascular medicine vol. 4 (2017): 51. doi: https://doi.org/10.3389/fcvm.2017.00051
Li M, Qian M, Xu J. Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Front Cardiovasc Med. 2017 Aug 09;4:51. doi: 10.3389/fcvm.2017.00051. eCollection 2017. PMID: 28848738; PMCID: PMC5552760.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries